F M Investments LLC Has $33.29 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

F M Investments LLC cut its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 13.2% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 65,814 shares of the healthcare conglomerate's stock after selling 10,051 shares during the period. UnitedHealth Group makes up about 1.2% of F M Investments LLC's holdings, making the stock its 15th largest holding. F M Investments LLC's holdings in UnitedHealth Group were worth $33,293,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently modified their holdings of the company. NewSquare Capital LLC purchased a new position in shares of UnitedHealth Group during the 4th quarter worth approximately $25,000. Hurley Capital LLC purchased a new stake in UnitedHealth Group during the 4th quarter worth about $28,000. Aster Capital Management DIFC Ltd purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth approximately $30,000. AlphaMark Advisors LLC purchased a new stake in shares of UnitedHealth Group in the 4th quarter valued at approximately $30,000. Finally, Promus Capital LLC purchased a new stake in shares of UnitedHealth Group during the 4th quarter worth $32,000. Institutional investors and hedge funds own 87.86% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on UNH. Wells Fargo & Company dropped their price objective on UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating on the stock in a report on Tuesday, January 28th. Hsbc Global Res upgraded UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research note on Friday, January 10th. Cantor Fitzgerald reiterated an "overweight" rating and issued a $700.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. HSBC upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 target price on the stock in a research report on Friday, January 10th. Finally, KeyCorp reaffirmed an "overweight" rating and issued a $650.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. Twenty-one investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Buy" and an average target price of $632.85.

UnitedHealth Group Trading Down 2.9 %

Shares of NYSE UNH traded down $17.68 during midday trading on Monday, hitting $581.79. The stock had a trading volume of 2,064,110 shares, compared to its average volume of 4,336,136. The company's 50-day simple moving average is $512.87 and its 200 day simple moving average is $541.80. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The firm has a market cap of $532.17 billion, a P/E ratio of 37.53, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. UnitedHealth Group Incorporated has a fifty-two week low of $438.50 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts' consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same period in the prior year, the business earned $5.83 EPS. The company's revenue for the quarter was up 6.8% compared to the same quarter last year. Research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a dividend of $2.10 per share. The ex-dividend date was Monday, March 10th. This represents a $8.40 annualized dividend and a yield of 1.44%. UnitedHealth Group's payout ratio is currently 54.19%.

Insider Buying and Selling

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the stock in a transaction on Friday, January 17th. The stock was acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.33% of the stock is currently owned by company insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.